Browse Articles

Discover research articles across all indexed journals

A transgenic mouse line with a 58 kb fragment deletion shows skeletal defects

Scientific Reports Ahmed Alamoudi, Dina Husein, Yoshio Ohyama et al. Feb 06, 2025 DOI: 10.1038/s41598-025-88559-3

Pre-siting of UAV stations for traffic accident assessment considering road dispersion

PLoS ONE Sizhe Wang, Yanying Shang Feb 06, 2025 DOI: 10.1371/journal.pone.0316431

This paper investigates the issue of pre-site selection for drone stations with the aim of enhancing the rapid assessment capability of urban road traffic accidents. Firstly, the influence of traffic accidents on urban traffic is analyzed, and the potential application of drones in rapid response at the accident scene is explored. A minimization model is constructed with the goal of minimizing the cost of accident handling and reducing traffic congestion. To solve this problem, we improved the simulated annealing algorithm by combining the multi-neighborhood strategy, adaptive neighborhood size, and adding a taboo list, and verified the effectiveness of the algorithm. The validity of the model is tested through simulation examples, and the impact of the drone coverage radius and the distribution of accident points on the model performance is explored through sensitivity analysis, providing management insights for the pre-site selection of drone stations.

The hepcidin-ferroportin axis modulates liver endothelial cell BMP expression to influence iron homeostasis in mice

Blood Allison L. Fisher, Sydney Phillips, Chia-Yu Wang et al. Feb 06, 2025 DOI: 10.1182/blood.2024024795

Abstract The liver hormone hepcidin regulates systemic iron homeostasis to provide enough iron for vital processes while limiting toxicity. Hepcidin acts by degrading its receptor ferroportin (encoded by Slc40a1) to decrease iron export to plasma. Iron controls hepcidin production in part by inducing liver endothelial cells (LECs) to produce bone morphogenetic proteins (BMPs) that activate hepcidin transcription in hepatocytes. Here, we used in vitro and in vivo models to investigate whether ferroportin contributes to LEC intracellular iron content to modulate BMP expression and, thereby, hepcidin. Quantitative proteomics of LECs from mice fed different iron diets demonstrated an inverse relationship between dietary iron and endothelial ferroportin expression. Slc40a1 knockdown primary mouse LECs and endothelial Slc40a1 knockout mice exhibited increased LEC iron and BMP ligand expression. Endothelial Slc40a1 knockout mice also exhibited altered systemic iron homeostasis with decreased serum and total liver iron but preserved erythropoiesis. Although endothelial Slc40a1 knockout mice had similar hepcidin expression to control mice, hepcidin levels were inappropriately high relative to iron levels. Moreover, when iron levels were equalized with iron treatment, hepcidin levels were higher in endothelial Slc40a1 knockout mice than in controls. Finally, LEC ferroportin levels were inversely correlated with hepcidin levels in multiple mouse models, and treatment of hepcidin-deficient mice with mini-hepcidin decreased LEC ferroportin expression. Overall, these data show that LEC ferroportin modulates LEC iron and consequently BMP expression to influence hepcidin production. Furthermore, LEC ferroportin expression is regulated by hepcidin, demonstrating a bidirectional communication between LECs and hepatocytes to orchestrate systemic iron homeostasis.

Ultrasound imaging of the perithyroid fascial space: a comparative analysis with anatomical correlations

Scientific Reports Ying Wei, Zhen-long Zhao, Yun Niu et al. Feb 06, 2025 DOI: 10.1038/s41598-025-88306-8

Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy in Sub-Saharan Africa: A scoping review

PLoS ONE Naa A. Buxton-Tetteh, Shakti Pillay, Gugulabatembunamahlubi T. J. Kali et al. Feb 06, 2025 DOI: 10.1371/journal.pone.0315100

Introduction There are divergent views and limited data regarding therapeutic hypothermia (TH) for neonatal hypoxic ischaemic encephalopathy (HIE) in sub-Saharan Africa (SSA). Our aim was to map and synthesize the published literature describing the use of TH for HIE in SSA, and the associated outcomes. Method We searched Pubmed, Scopus, Google Scholar, and Web of Science from 1 January 1996 to 31 December 2023 for research studies, protocols, feasibility studies and surveys on term and near-term babies with HIE (population) treated with TH (concept) in SSA (context). Results Thirty records were included: Three surveys, one feasibility study and 26 publications describing 23 studies of 21 cohorts, cooling 1420 babies in South Africa, Uganda, and Ghana. There were five studies recruiting at follow-up, five pilot studies, one randomised controlled trial, one case series, and 10 birth cohorts. The methods and design of the studies were highly variable and often inadequate. Only three studies with adequately described and validated cooling methods, non-selective sequential recruitment, and neurological outcomes were identified. Two studies of babies from birth, both with intensive care facilities, reported survival with normal/mildly abnormal outcome in 71% at discharge in one study, and 71% at 12 months in another, with 16% cerebral palsy (CP) in survivors, and only 16% loss to follow-up. The third study, which only included clinic attenders after TH without intensive care, reported 7% CP in survivors, but 36% loss to follow-up. Conclusions Data from the adequately described TH studies in SSA indicate outcomes at discharge and twelve months which are similar to global norms. However, these data are limited to South Africa. Interpretation of other studies was limited by loss to follow-up, variable methodology and exclusion of babies with severe HIE in some studies. There is a need for standardised definitions to facilitate interpretation in TH studies.

BMPs and iron: the ins and outs

Blood Nermi L. Parrow, Robert E. Fleming Feb 06, 2025 DOI: 10.1182/blood.2024027052

A hybrid differential evolution particle swarm optimization algorithm based on dynamic strategies

Scientific Reports Huarong Xu, Qianwei Deng, Zhiyu Zhang et al. Feb 06, 2025 DOI: 10.1038/s41598-024-82648-5

What went wrong at 23andMe? Why the genetic-data giant risks collapse

Nature Diana Kwon Feb 06, 2025 DOI: 10.1038/d41586-025-00118-y

Bilateral internal iliac artery ligation in trauma patients with severe pelvic hemorrhage: A systematic review

PLoS ONE Soon Tak Jeong, Do Wan Kim, Wu Seong Kang Feb 06, 2025 DOI: 10.1371/journal.pone.0303476

Introduction Severe pelvic hemorrhage significantly contributes to mortality in trauma patients, yet the most effective treatment for severe pelvic injuries remains unclear. This systematic review evaluates the mortality and morbidity associated with bilateral internal iliac artery ligation (BIIAL) in patients experiencing severe hemorrhage from traumatic pelvic fractures. Methods Comprehensive searches were conducted in MEDLINE PubMed, EMBASE, and Cochrane databases until February 7, 2024, to identify relevant articles. The risk of bias in observational studies was assessed using the ROBINS-I tool, which evaluates bias risk in nonrandomized intervention studies. The primary outcome was mortality following BIIAL, with the secondary outcome being complications related to the procedure. Results The review included eight studies, all observational. The overall mortality rate after BIIAL ranged from 45.0% to 76.9%. Ischemic complications from BIIAL were infrequent. A high and unclear risk of bias due to confounding and participant selection was noted across the studies. Four studies highlighted distinct indications for BIIAL compared to angioembolization. BIIAL was employed for patients with severe hemodynamic instability or when angiography was not available. Conclusion Due to geographical limitations and significant heterogeneity among the studies reviewed, the true effect size of BIIAL remains indeterminate. Nevertheless, further prospective studies with robust designs are necessary. BIIAL holds potential as a viable option when angioembolization is not accessible or in cases of critical patient instability.

No exit: targeting RNA export in T-cell malignancy

Blood Katherine L. B. Borden Feb 06, 2025 DOI: 10.1182/blood.2024027322

Assessing the diagnostic accuracy of machine learning algorithms for identification of asthma in United States adults based on NHANES dataset

Scientific Reports Omid Kohandel Gargari, Mobina Fathi, Shahryar Rajai Firouzabadi et al. Feb 06, 2025 DOI: 10.1038/s41598-025-88345-1

Correction: Human-machine interactions with clinical phrase prediction system, aligning with Zipf’s least effort principle?

PLoS ONE Feb 06, 2025 DOI: 10.1371/journal.pone.0319185

CNS relapse in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements and dark-zone signature–expressing DLBCL

Blood Waleed Alduaij, Aixiang Jiang, Diego Villa et al. Feb 06, 2025 DOI: 10.1182/blood.2024025725

Abstract High-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2), or “double-hit lymphoma,” has been associated with a high risk of central nervous system (CNS) relapse. However, historic estimates are impacted by selection bias. We report CNS relapse rates associated with HGBCL-DH-BCL2 from a population-based cohort with complete fluorescence in situ hybridization testing, as well as diffuse large B-cell lymphoma morphology (DLBCL) tumors expressing the dark-zone gene expression signature (DZsig), which was originally derived from HGBCL-DH-BCL2. The 2-year CNS relapse risk in HGBCL-DH-BCL2 was 6.8%. CNS relapses were early, predominantly leptomeningeal (73%), and co-occurred with systemic relapse (64%). High-risk CNS International Prognostic Index (CNS-IPI) and concordant bone marrow involvement were associated with an elevated CNS relapse risk in HGBCL-DH-BCL2. The “refined cell-of-origin” classification assigned 20% of DLBCL morphology tumors with germinal center B-cell–like phenotype (GCB-DLBCL) into a distinct subgroup based on DZsig expression (DZsig+). CNS relapse risk in DZsig+ (2 year: 6.4%) was independent of HGBCL-DH-BCL2 status and was further stratified by the CNS-IPI. CNS relapse in DZsig-negative GCB-DLBCL was rare (2-year risk, 1.4%; P = .04 vs DZsig+) and exclusively parenchymal. Altogether, the CNS relapse risk in HGBCL-DH-BCL2 is lower than previously reported, and DZsig refines risk stratification in GCB-DLBCL.

The effect of prednisolone ingestion and acute exercise on lipocalin-2 and its variants in young men: a pilot randomised crossover study

Scientific Reports Carlie Bauer, Rhiannon K. Patten, Qiyang Sun et al. Feb 06, 2025 DOI: 10.1038/s41598-025-88115-z

Correction: Parity and post-reproductive mortality among U.S. Black and White women: Evidence from the Health and Retirement Study

PLoS ONE Feb 06, 2025 DOI: 10.1371/journal.pone.0319187

The GATA-3–dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas

Blood Nermin Kady, Suhaib Abdelrahman, Ahmar M. Rauf et al. Feb 06, 2025 DOI: 10.1182/blood.2024025484

Abstract The transcription factor GATA-binding protein 3 (GATA-3) and the transcriptional program it regulates have emerged as oncogenic drivers across diverse T-cell lymphomas (TCLs), many of which are resistant to conventional chemotherapeutic agents and characterized by recurrent losses of key tumor suppressor genes, including TP53 and PTEN, both of which are clients of the nuclear export protein XPO1. Here, we demonstrated that XPO1 is highly expressed by malignant T cells expressing GATA-3 and by lymphoma-associated macrophages (LAMs) within their tumor microenvironment (TME). Using complementary genetically engineered mouse models, we demonstrated that TP53- and/or phosphate and tensin homolog (PTEN)-deficient TCLs, and LAMs within their TME, are sensitive to the selective exportin-1 (XPO1) antagonist selinexor. In an effort to identify TP53- and PTEN-independent mechanisms, we used complementary and orthogonal approaches to investigate the role of eIF4E and XPO1-dependent messenger RNA nuclear export in these TCLs. We identified a novel role for eIF4E/XPO1 in exporting GATA-3 and GATA-3–dependent transcripts from the nucleus in TCLs, and in the export of therapeutically relevant transcripts, including colony-stimulating factor-1 receptor, from LAMs. Therefore, XPO1 antagonism, by impairing oncogenic transcriptional programs in TCLs and depleting LAMs from their TME, is a novel approach to target 2 independent dependencies in a group of therapeutically challenging TCLs.

Publisher Correction: Antioxidant activity of Micractinium sp. (Chlorophyta) extracts against H2O2 induced oxidative stress in human breast adenocarcinoma cells

Scientific Reports Onur Bulut, Işkın Engin Köse, Çağla Sönmez et al. Feb 06, 2025 DOI: 10.1038/s41598-025-87734-w

LazyAct: Lazy actor with dynamic state skip based on constrained MDP

PLoS ONE Hongjie Zhang, Zhenyu Chen, Hourui Deng et al. Feb 06, 2025 DOI: 10.1371/journal.pone.0318778

Deep reinforcement learning has achieved significant success in complex decision-making tasks. However, the high computational cost of policies based on deep neural networks restricts their practical application. Specifically, each decision made by an agent requires a complete neural network computation, leading to a linear increase in computational cost with the number of interactions and agents. Inspired by human decision-making patterns, which involve reasoning only on critical states in continuous decision-making tasks without considering all states, we introduce the LazyAct algorithm. This algorithm significantly reduces the number of inferences while preserving the quality of the policy. Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. Subsequently, we establish optimization objectives for single-agent and multi-agents inference, incorporating cost constraints based on the IMPALA and MAPPO frameworks, respectively. Finally, we utilize pre-training and fine-tuning techniques to train the policy network. Extensive experimental results indicate that LazyAct reduces the number of inferences by approximately 80% and 40% in single-agent and multi-agents scenarios, respectively, while sustaining comparable policy performance. The inferences reduction significantly decreases the time and FLOPs required by the LazyAct algorithm to complete tasks. Code is available here https://www.dropbox.com/scl/fo/wyoqo6q9gyt86zobfgbvx/h?\rlkey=0moyxsnoiisfs9y4h89hsou1l&amp;dl=0.

Menin inhibitors in the treatment of acute myeloid leukemia

Blood Gerwin Huls, Carolien M. Woolthuis, Jan Jacob Schuringa Feb 06, 2025 DOI: 10.1182/blood.2024026232

Abstract Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the (oligo)clonal expansion of myeloid progenitor cells. Despite advances in treatment, AML remains challenging to cure, particularly in patients with specific genetic abnormalities. Menin inhibitors have emerged as a promising therapeutic approach, targeting key genetic drivers of AML, such as KMT2A (lysine methyl transferase 2A) rearrangements and NPM1 mutations. Here, we review the clinical value of menin inhibitors, highlighting their mechanism of action, efficacy, safety, and potential to transform AML treatment.

Author Correction: Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose

Scientific Reports Nao Iguchi, Ali Teimouri, Duncan T. Wilcox et al. Feb 06, 2025 DOI: 10.1038/s41598-025-88768-w